|
| 35760800 | Osteocyte CIITA aggravates osteolytic bone lesions in myeloma. | Nat Commun | 2022 |
| 34249457 | <i>ATF4</i> loss of heterozygosity is associated with poor overall survival in medullary thyroid carcinoma. | Am J Cancer Res | 2021 |
| 33536187 | ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of <i>RET</i>, <i>VEGFR2</i>, and <i>IGFBP2</i>. | Mol Cancer Ther | 2021 |
| 32464600 | HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Early thyroidectomy in multiple endocrine neoplasia: a four decade experience. | Endocr Relat Cancer | 2020 |
| 32580150 | HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The state of science in medullary thyroid carcinoma: current challenges and unmet needs. | Endocr Relat Cancer | 2020 |
| 32508314 | History of the multiple endocrine neoplasia workshops and overview of MEN2019. | Endocr Relat Cancer | 2020 |
| 32437031 | Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. | Head Neck | 2020 |
| 30557850 | Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer. | Endocr Relat Cancer | 2019 |
| 31532726 | Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline. | J Clin Oncol | 2019 |
| 31010875 | Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). | Diabetes Care | 2019 |
| 30859653 | Tumor-induced hypophosphatemic osteomalacia caused by a mesenchymal tumor of the mandible managed by a segmental mandibulectomy and microvascular reconstruction with a free fibula flap. | Head Neck | 2019 |
| 30858546 | Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer. | Oncogene | 2019 |
| 30552230 | Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress-Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer. | Mol Cancer Res | 2019 |
| 29197959 | Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience. | Support Care Cancer | 2018 |
| 30151621 | Correction to: Hip fracture trends in the United States, 2002 to 2015. | Osteoporos Int | 2018 |
| 29427212 | Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. | Ann Surg Oncol | 2018 |
| 29282482 | Hip fracture trends in the United States, 2002 to 2015. | Osteoporos Int | 2018 |
| 27864651 | All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients. | Fam Cancer | 2017 |
| 28666011 | Differential effects of Calca-derived peptides in male mice with diet-induced obesity. | PLoS One | 2017 |
| 28609830 | Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. | J Clin Endocrinol Metab | 2017 |
| 27935748 | ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer. | J Clin Endocrinol Metab | 2017 |
| 26896384 | Incidence of Atypical Femur Fractures in Cancer Patients: The MD Anderson Cancer Center Experience. | J Bone Miner Res | 2016 |
| 28018583 | Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial. | Bonekey Rep | 2016 |
| 27673361 | Medullary Thyroid Carcinoma Associated with Germline RET<sup>K666N</sup> Mutation. | Thyroid | 2016 |
| 27610696 | Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma. | Thyroid | 2016 |
| 27662441 | Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. | J Clin Endocrinol Metab | 2016 |
| 27454359 | Changing of the Guard. | Endocr Rev | 2016 |
| 27559096 | Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma. | Sci Transl Med | 2016 |
| 27229335 | The National Osteoporosis Foundation's methods and processes for developing position statements. | Arch Osteoporos | 2016 |
| 26750746 | Proceedings of the 2015 Santa Fe Bone Symposium: Clinical Applications of Scientific Advances in Osteoporosis and Metabolic Bone Disease. | J Clin Densitom | 2016 |
| 25795775 | A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis. | J Biol Chem | 2015 |
| 28580383 | Resection of granulomatous tissue resolves silicone induced hypercalcemia. | Bone Rep | 2015 |
| 26494392 | Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma. | Recent Results Cancer Res | 2015 |
| 26151398 | My, How Things Have Changed in Multiple Endocrine Neoplasia Type 2A! | J Clin Endocrinol Metab | 2015 |
| 26174815 | Treatment of osteoporosis is not futile. | BMJ | 2015 |
| 26240982 | Changing of the Guard. | Endocr Rev | 2015 |
| 25810047 | Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. | Thyroid | 2015 |
| 23829280 | Atypical chronic lymphocytic leukemia with polyglandular autoimmune endocrinopathy type II: a complex profile. | Leuk Lymphoma | 2014 |
| 24617864 | Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. | Thyroid | 2014 |
| 23185034 | The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring. | J Clin Endocrinol Metab | 2013 |
| 24127332 | A miRNA signature associated with human metastatic medullary thyroid carcinoma. | Endocr Relat Cancer | 2013 |
| 23997241 | NCCN Task Force Report: Bone Health In Cancer Care. | J Natl Compr Canc Netw | 2013 |
| 23978590 | Diabetes and cancer--an AACE/ACE consensus statement. | Endocr Pract | 2013 |
| 24030942 | The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. | J Clin Endocrinol Metab | 2013 |
| 23462960 | Lactating Ctcgrp nulls lose twice the normal bone mineral content due to fewer osteoblasts and more osteoclasts, whereas bone mass is fully restored after weaning in association with up-regulation of Wnt signaling and other novel genes. | Endocrinology | 2013 |
| 23526213 | Deletion of the gene encoding calcitonin and calcitonin gene-related peptide α does not affect the outcome of severe infection in mice. | Am J Respir Cell Mol Biol | 2013 |
| 22025146 | Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. | J Clin Oncol | 2012 |
| 20946574 | Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients. | Ann N Y Acad Sci | 2011 |
| 22193147 | Activation of G-protein-coupled receptors and thyroid malignant tumors: the jury is still out. | Endocr Pract | 2011 |
| 21606412 | Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer. | J Clin Oncol | 2011 |